login
login

Europe Daily Bulletin No. 8514

30 July 2003
Contents Publication in full By article 27 / 28
ECONOMIC INTERPENETRATION / (eu) pharmaceuticals

Switzerland's ROCHE has bought up US company IGEN for $47.25 a share, making a total of around $1.3 bn. Alongside their $47.25 for each share, IGEN's shareholders will receive one share in the brand new company holding the ORIGEN brand.

Contents

THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION